YM-872 (Yamanouchi Pharmaceutical Co.) is an a-amino-3-(3-hydroxy-5-methylisoxazole-4-yl)-propanoic acid antagonist. A dose-finding trial with this agent was completed without any safety concerns. A Phase 2 trial has been completed, in which patients were randomized to a 24-hr IV infusion of YM-872 or placebo within 6 hr of symptom onset. Patients with brain stem or cerebellar infarcts were excluded. Magnetic resonance imaging, including diffusion-weighted imaging and perfusion-weighted imaging, was performed prior to the randomization of each patient and again after 1 month. Although no significant safety concerns were noted, no significant treatment benefits were detected (Company press release, Yamanouchi Pharmaceutical).

Was this article helpful?

0 0
Metabolism Masterclass

Metabolism Masterclass

Are You Sick And Tired Of All The Fat-Burning Tricks And Trends That Just Don’t Deliver? Well, Get Set To Discover The Easy, Safe, Fast, And Permanent Way To Mega-Charge Your Metabolism And Lose Excess Fat Once And For All! This Weight Blasting Method Is Easy AND Natural… And Will Give You The Hot Body And Killer Energy Levels You’ve Been Dreaming Of.

Get My Free Ebook

Post a comment